SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Director declaration and resignation

27 Oct 2022 09:30

RNS Number : 2528E
Porvair PLC
27 October 2022
 

FOR IMMEDIATE RELEASE 27 October 2022

 

 

Director declaration and resignation

 

In accordance with paragraph 9.6.14 R of the Listing Rules, Jasi Halai, Non-Executive Director, has advised that she will become an independent non-executive director of Barratt Developments PLC with effect from 1 January 2023.

 

Jasi will retire from the Board of Porvair plc at the end of January 2023, following publication of the audited results for the year ending 30 November 2022. In the three years that she has been an independent Non-Executive Director, she has been a valued member of the Board and made a very constructive contribution to the direction, strategy and control of the business. We thank her and wish her well. 

The search for her successor is well advanced and will be announced in due course.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Chris Tyler, Group Company Secretary

 

Notes to Editors

Porvair is a group of specialist filtration, laboratory and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZMZGRVFGZZM
Date   Source Headline
27th Mar 20257:00 amRNSGrant of SAYE Options
18th Mar 20257:40 amRNSHolding(s) in Company
17th Mar 20253:30 pmRNSHolding(s) in Company
14th Mar 20257:00 amRNSNotice of Annual General Meeting; Accounts posting
4th Mar 20253:00 pmRNSHolding(s) in Company
12th Feb 20252:30 pmRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSFull Year Results
12th Dec 20241:00 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSTrading update and notice of results
2nd Dec 20243:01 pmRNSTotal Voting Rights
2nd Dec 20243:00 pmRNSDirector/PDMR Shareholding
25th Nov 20244:37 pmRNSShareholder Communications
28th Oct 20247:00 amRNSBoard appointment
1st Oct 20247:00 amRNSTotal Voting Rights
23rd Sep 20247:00 amRNSAppointment of Chief Executive Officer
2nd Sep 20245:15 pmRNSDirector/PDMR Shareholding
2nd Sep 20245:00 pmRNSTotal Voting Rights
31st Jul 202410:45 amRNSTotal Voting Rights
31st Jul 202410:30 amRNSBlock listing Interim Review
29th Jul 20246:15 pmRNSDirector/PDMR Shareholding
1st Jul 20247:00 amRNSInterim Results
27th Jun 20242:26 pmRNSDirector/PDMR Shareholding
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.